Collectively, these discoveries highlight the potential roles of Ptprc and Apoe in the pathogenesis of ARVC and HF, providing new insights into the molecular mechanisms underlying PKP2‐related cardiac dysfunction and fibrosis. The gene discussed is PTPRC; the disease is arrhythmogenic right ventricular cardiomyopathy.